Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions

The largest strategic meeting on medical cannabis and hemp in Brazil takes place in São Paulo, bringing together researchers, entrepreneurs, and professionals who are shaping the country's green future

During the 4th Brazilian Medicinal Cannabis Congress, the president of Sindusfarma emphasized that only clear and responsible regulation can ensure quality, trust, and safe access to plant-derived products.

Cannabis-based product deliveries are reaching the most remote places in Brazil, revealing the strength of a growing market

Public consultation allows society to express opinions on the agency's priorities for the next two years; preliminary list does not include cannabis

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

In Deusa Cast, a lawyer explains how Customs and Criminal Law act in preventing risks in the importation of cannabis-based products, ensuring safety and agility for companies in the sector

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

Social Affairs Committee confirms Safatle, Cerqueira, and Cardoso's names, in a moment of important reforms at the agency

Social Affairs Committee to analyze four names for leadership positions in health agencies

Shipping cannabis products via the Post Office is still prohibited, but companies are finding specialized solutions to meet the growing demand of the medicinal market

General coordinator details the efforts made by the public agency

With Anvisa's regulation, the use of medical cannabis for animals is starting to gain traction, benefiting the pet sector, veterinary medicine, and the medical cannabis market.

Experts discuss the importance of integrativity in cannabinoid dentistry and the legal certainty of the process

In Brazil alone, the medicinal market is expected to reach over R$ 600 million in 2023, according to a report by the data intelligence company Kaya Mind

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control

Patients who rely on medicinal cannabis face legal battles and, in many cases, imprisonment. Understand the challenges of access, the legal impacts, and the stories of those fighting for the right to treatment in Brazil.

The Brazilian Association of Cannabinoid Industry (BRcann) forum brought together sector representatives and Anvisa to discuss regulatory updates, research, information, and market

The Brazilian Association of Pharmaceutical Inputs Industry trusts that the request for a view by director Thiago Campos will result in a more in-depth analysis, maintaining the expectation of concluding the regulatory framework in January 2026